Interfacility transport of the critically ill pediatric patient

Samuel J Ajizian1, Thomas A Nakagawa

  • 1Department of Anesthesiology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1009, USA. sajizian@wfubmc.edu

Chest
|October 16, 2007
PubMed

Insights

Pediatric critical care transport teams provide specialized care for critically ill children. Despite evolving standards and improved outcomes, these essential services face financial challenges due to declining reimbursement and budget constraints.

Area of Science:

  • Pediatric Critical Care Medicine
  • Emergency Medical Services
  • Healthcare Management

Background:

  • Significant advancements in pediatric critical care over two decades.
  • Emergence of regional pediatric critical care services and subspecialties.
  • Recognition of specialized care needs during interfacility transport of critically ill children.

Purpose of the Study:

  • To examine the evolution and current state of pediatric critical care transport.
  • To highlight the role of specialized transport teams in improving patient outcomes.
  • To address the financial and operational challenges faced by these teams.

Main Methods:

  • Review of the development of pediatric critical care transport services.
  • Incorporation of standards from organizations like the American Academy of Pediatrics Section on Transport Medicine.
  • Analysis of team composition, mission, and operational factors.

Main Results:

  • Pediatric transport teams are crucial for safe and expeditious care of critically ill children.
  • These specialized teams are costly to maintain.
  • Declining reimbursement and budget constraints impact service sustainability and team roles.

Conclusions:

  • Pediatric critical care transport has evolved significantly, improving patient outcomes.
  • Financial sustainability is a major challenge for specialized pediatric transport teams.
  • Adapting to budgetary constraints requires innovative solutions to maintain service quality.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...